BCAL Diagnostics Ltd
ASX:BDX

Watchlist Manager
BCAL Diagnostics Ltd Logo
BCAL Diagnostics Ltd
ASX:BDX
Watchlist
Price: 0.125 AUD -3.85% Market Closed
Market Cap: 46m AUD

Operating Margin
BCAL Diagnostics Ltd

-273.5%
Current
-278%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-273.5%
=
Operating Profit
-7.2m
/
Revenue
2.7m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
BCAL Diagnostics Ltd
ASX:BDX
45.7m AUD
-274%
IL
Can Fite Biopharma Ltd
TASE:CANF
154.5T ILS
-1 487%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
393.6B USD
33%
US
Amgen Inc
NASDAQ:AMGN
175.5B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
151.8B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.2B USD
28%
AU
CSL Ltd
ASX:CSL
84B AUD
26%
NL
argenx SE
XBRU:ARGX
42.4B EUR
22%
No Stocks Found

BCAL Diagnostics Ltd
Glance View

Market Cap
45.7m AUD
Industry
Biotechnology

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The firm is developing a blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, accurate and available to all women regardless of age, race and geographic location. The company has developed a non-invasive blood test for the detection of breast cancer. The firm is developing an in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vehicles (EVs) from a patient's plasma or blood sample to diagnose the presence of cancer cells in a patient’s body. BCAL has partnered with integrated cancer care and cardiac provider GenesisCare to conduct clinical research required for regulatory approvals across jurisdictions.

BDX Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-273.5%
=
Operating Profit
-7.2m
/
Revenue
2.7m
What is the Operating Margin of BCAL Diagnostics Ltd?

Based on BCAL Diagnostics Ltd's most recent financial statements, the company has Operating Margin of -273.5%.

Back to Top